VIMTA LABS
|
The Current P/S Ratio of VIMTA LABS is 5.69.
| Share Price | ₹427.6 | Mar 20,2026 |
| Market Cap | ₹1,911.1 Cr | |
| Sales-TTM | ₹336.1 Cr | TTM-Consolidated Results |
| Price/Sales | 5.69x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of VIMTA LABS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹1,911.1 Cr] as on Mar 20,2026
(/) Sales [ ₹336.1 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 5.69x ]
Thus, for VIMTA LABS , the investors are currently willing to pay '5.69 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of VIMTA LABS !
The chart below summarizes the trend in P/S Ratio of VIMTA LABS over the last five years.
Historical PS (Price/Sales) ratio chart of VIMTA LABS
PS Ratio Performance Analysis for VIMTA LABS
- VIMTA LABS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 2.04x.
- VIMTA LABS 's operated at median p/e ratio of 2.19x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, VIMTA LABS 's p/e ratio peaked in Mar2024 at 3.1x.
- VIMTA LABS 's p/e ratio hit its five-year low in Mar2020 of 0.72x.
How does VIMTA LABS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| VIMTA LABS | 336.1 | 5.69 | 1,911.1 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 56,809.1 | 7.51 | 426,470.0 |
| DIVIS LABORATORIES LTD | 10,314.0 | 15.71 | 161,996.0 |
| CIPLA LTD | 28,351.1 | 3.58 | 101,445.0 |
| TORRENT PHARMACEUTICALS LTD | 12,742.0 | 11.34 | 144,440.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 3.13 | 108,417.0 |
| MANKIND PHARMA LTD | 13,914.1 | 5.93 | 82,555.3 |
| ZYDUS LIFESCIENCES LTD | 26,089.3 | 3.43 | 89,615.2 |
| LUPIN LTD | 26,150.5 | 4.06 | 106,146.0 |
| AUROBINDO PHARMA LTD | 33,181.9 | 2.26 | 75,004.7 |
| ABBOTT INDIA LTD | 6,824.1 | 8.32 | 56,804.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs VIMTA LABS 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.26x |
| Max industry PS | 15.71x |
| Median industry PS | 5.69x |
| Average industry PS | 6.45x |
You may also like the below Video Courses